Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by Current Cardiff authors

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Number of items: 10.

White, P. Lewis, Parr, Christian and Barnes, Rosemary A. 2018. Predicting invasive aspergillosis in haematology patients by combining clinical and genetic risk factors with early diagnostic biomarkers. Journal of Clinical Microbiology 56 (1) , e01122-17. 10.1128/JCM.01122-17
file

White, P., Parr, Christian, Thornton, C. and Barnes, Rosemary 2013. Evaluation of Real-Time PCR, Galactomannan Enzyme-Linked Immunosorbent Assay (ELISA), and a novel lateral-flow device for diagnosis of invasive aspergillosis. Journal of Clinical Microbiology 51 (5) , pp. 1510-1516. 10.1128/JCM.03189-12

Sanders, Andrew James, Parr, Christian, Davies, Gaynor, Martin, Tracey Amanda, Lane, Jane, Mason, Malcolm David and Jiang, Wen Guo 2006. Genetic reduction of matriptase-1 expressionj is associated with a reduction in the aggressive phenotype of prostate cancer cells in vitro and in vivo. Journal of Experimental Therapeautics and Oncology 6 (1) , pp. 39-48.

Sanders, Andrew James, Parr, Christian, Davies, Gaynor, Martin, Tracey Amanda, Lane, Jane, Mason, Malcolm David and Jiang, Wen Guo 2006. Genetic reduction of matriptase-1 expression is associated with a reduction in the aggressive phenotype of prostate cancer cells in vitro and in vivo. Journal of Experimental Therapeutics and Oncology 6 (1) , pp. 39-48.

Davies, Gaynor, Mason, Malcolm David, Martin, Tracey Amanda, Parr, Christian, Watkins, Gareth, Lane, Jane, Jiang, Wen Guo, Matsumoto, Kunio and Nakamura, Toshikazu 2003. The HGF/SF antagonist NK4 reverses fibroblast- and HGF-induced prostate tumor growth and angiogenesisin vivo. International Journal of Cancer 106 (3) , pp. 348-354. 10.1002/ijc.11220

Parr, Christian, Davies, G., Nakamura, T., Matsumoto, Kei, Mason, Malcolm David and Jiang, Wen Guo 2001. The HGF/SF-induced phosphorylation of paxillin, matrix adhesion, and invasion of prostate cancer cells were suppressed by NK4, an HGF/SF variant. Biochemical and Biophysical Research Communications 285 (5) , pp. 1330-1337. 10.1006/bbrc.2001.5307

Parr, Christian and Jiang, Wen Guo 2001. Hepatocyte growth factor activators, inhibitors and antagonists and their implication in cancer intervention. Histology and Histopathology 16 (1) , pp. 251-268.

Parr, Christian, Hiscox, Stephen Edward, Nakamura, Toshikazu, Matumoto, Kunio and Jiang, Wen Guo 2000. NK4, a new HGF/SF variant, is an antagonist to the influence of HGF/SF on the motility and invasion of colon cancer cells. International Journal of Cancer 85 (4) , pp. 563-570. 10.1002/(SICI)1097-0215(20000215)85:4<563::AID-IJC19>3.0.CO;2-D

Hiscox, Stephen Edward, Parr, Christian, Nakamura, Toshikazu, Matsumoto, Kunio, Jiang, Wen Guo and Mansel, Robert Edward 2000. Inhibition of HGF/SF-induced breast cancer cell motility and invasion by the HGF/SF variant, NK4. British Journal of Cancer 59 (3) , pp. 245-254. 10.1023/A:1006348317841

Jiang, Wen Guo, Hiscox, Stephen Edward, Parr, Christian, Martin, Tracey Amanda, Matsumoto, Kunio, Nakamura, Toshikazu and Mansel, Robert Edward 1999. Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells. Clinical Cancer Research 5 (11) , pp. 3695-3703.

This list was generated on Tue Mar 26 03:45:03 2019 GMT.